Literature DB >> 14688797

Indications for peripheral light-chain revision and somatic hypermutation without a functional B-cell receptor in precursors of a composite diffuse large B-cell and Hodgkin's lymphoma.

Richard Rosenquist1, Fabio Menestrina, Maurizio Lestani, Ralf Küppers, Martin-Leo Hansmann, Andreas Bräuninger.   

Abstract

Composite lymphomas are rare combinations of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma in the same patient, where clonal relatedness has been observed in most of the few cases analyzed. Here, we report a composite classical HL and diffuse large B-cell lymphoma (DLBCL) with interesting molecular features. Micromanipulation of single cells and analysis of V gene rearrangements revealed clonal relatedness with shared and distinct mutations, indicative of derivation from a common germinal center (GC) B-cell precursor and also of further development of both lymphomas in a GC. In the DLBCL, a very high mutation load, including inactivating mutations, and two copies of the same clonal rearrangement with different mutations in single cells were observed. Intriguingly, in the DLBCL precursor somatic hypermutation activity continued after acquisition of destructive V gene mutations, a feature previously found only in Epstein-Barr virus (EBV) infected B-cell expansions. Furthermore, we found evidence of light-chain receptor revision in the lymphoma precursor during a GC reaction. Re-expression of the V(D)J recombination machinery may enhance genomic instability in GC B cells and contribute to lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688797     DOI: 10.1038/labinvest.3700025

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  5 in total

Review 1.  Composite diffuse large B-cell lymphoma and classical Hodgkin's lymphoma of the stomach: case report and literature review.

Authors:  Hong-Wei Wang; Wen Yang; Lin Wang; Yun-Long Lu; Jiang-Yang Lu
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

2.  Insights into the regulation of immunoglobulin light chain gene rearrangements via analysis of the kappa light chain locus in lambda myeloma.

Authors:  Vittorio Perfetti; Maurizio C Vignarelli; Giovanni Palladini; Valentina Navazza; Claudia Giachino; Giampaolo Merlini
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 3.  Composite lymphoma in the anterior mediastinum: a case report and review of the literature.

Authors:  Guohua Yu; Lingling Kong; Guimei Qu; Qian Zhang; Wei Wang; Lei Jiang
Journal:  Diagn Pathol       Date:  2011-07-06       Impact factor: 2.644

4.  Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.

Authors:  Cristina López; Kortine Kleinheinz; Sietse M Aukema; Marius Rohde; Stephan H Bernhart; Daniel Hübschmann; Rabea Wagener; Umut H Toprak; Francesco Raimondi; Markus Kreuz; Sebastian M Waszak; Zhiqin Huang; Lina Sieverling; Nagarajan Paramasivam; Julian Seufert; Stephanie Sungalee; Robert B Russell; Julia Bausinger; Helene Kretzmer; Ole Ammerpohl; Anke K Bergmann; Hans Binder; Arndt Borkhardt; Benedikt Brors; Alexander Claviez; Gero Doose; Lars Feuerbach; Andrea Haake; Martin-Leo Hansmann; Jessica Hoell; Michael Hummel; Jan O Korbel; Chris Lawerenz; Dido Lenze; Bernhard Radlwimmer; Julia Richter; Philip Rosenstiel; Andreas Rosenwald; Markus B Schilhabel; Harald Stein; Stephan Stilgenbauer; Peter F Stadler; Monika Szczepanowski; Marc A Weniger; Marc Zapatka; Roland Eils; Peter Lichter; Markus Loeffler; Peter Möller; Lorenz Trümper; Wolfram Klapper; Steve Hoffmann; Ralf Küppers; Birgit Burkhardt; Matthias Schlesner; Reiner Siebert
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

5.  Lambda light chain revision in the human intestinal IgA response.

Authors:  Wen Su; John N Gordon; Francesca Barone; Laurent Boursier; Wayne Turnbull; Surangi Mendis; Deborah K Dunn-Walters; Jo Spencer
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.